KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Deferred Taxes (2018 - 2024)

Vir Biotechnology (VIR) has disclosed Deferred Taxes for 3 consecutive years, with -$2.6 million as the latest value for Q4 2024.

  • Quarterly Deferred Taxes fell 148.64% to -$2.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$3.6 million through Dec 2024, changed N/A year-over-year, with the annual reading at -$2.9 million for FY2024, 177.42% down from the prior year.
  • Deferred Taxes hit -$2.6 million in Q4 2024 for Vir Biotechnology, down from $57000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $57000.0 in Q3 2024 to a low of -$2.6 million in Q4 2024.